Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-14

Clinical Trial Update: Clinical Study of Clevidipine Butyrate Injection in the Treatment of Hypertensive Emergency and Sub-emergency [Phase 3]

View source ↗

Summary

A Phase 3 clinical study evaluating clevidipine butyrate injection for hypertensive emergency is ongoing; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clevidipine Butyrate Injection (clevidipine butyrate)

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Hypertensive Emergency | Phase 3 | Status: UNKNOWN